ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 70 filers reported holding ALPINE IMMUNE SCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $1,777,497 | -60.3% | 44,841 | -80.9% | 0.25% | -65.3% |
Q4 2023 | $4,476,069 | +117.2% | 234,841 | +30.5% | 0.72% | +92.0% |
Q3 2023 | $2,061,000 | +0.2% | 180,000 | -10.0% | 0.38% | +16.8% |
Q2 2023 | $2,056,000 | +33.2% | 200,000 | 0.0% | 0.32% | +24.4% |
Q1 2023 | $1,544,000 | +5.0% | 200,000 | 0.0% | 0.26% | -18.1% |
Q4 2022 | $1,470,000 | +2.1% | 200,000 | 0.0% | 0.32% | +57.5% |
Q3 2022 | $1,440,000 | -31.5% | 200,000 | +0.9% | 0.20% | +24.2% |
Q1 2021 | $2,102,000 | -15.9% | 198,260 | 0.0% | 0.16% | -27.5% |
Q4 2020 | $2,498,000 | +43.3% | 198,260 | 0.0% | 0.22% | +29.8% |
Q3 2020 | $1,743,000 | – | 198,260 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|